Multidrug-resistant Salmonella enteric serotype typhi, Gulf of Guinea Region, Africa

Emerging Infectious Diseases

Volumn 21, Issue 4, 2015, Pages 655-659

  Baltazar, Murielle ^a,b   Ngandjio, Antoinette ^a,e   Holt, Kathryn Elizabeth ^f,g   Lepillet, Elodie ^a   De La Gandara, Maria Pardos ^a,c   Collard, Jean Marc ^h   Bercion, Raymond ^d,i   Nzouankeu, Ariane ^e   Le Hello, Simon ^a   Dougan, Gordon ^g   Fonkoua, Marie Christine ^e   Weill, François Xavier ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c ROCKEFELLER UNIVERSITY   (United States)

^d INSTITUT PASTEUR DE DAKAR   (Senegal)

^e CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^h SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

ⁱ INSTITUT PASTEUR DE BANGUI   (Central African Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; QUINOLONE; STREPTOMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

AFRICA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HUMAN; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; DRUG EFFECTS; GENETICS; GEOGRAPHY; GUINEA; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SALMONELLA ENTERICA SEROVAR TYPHI; SINGLE NUCLEOTIDE POLYMORPHISM; TYPHOID FEVER;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENETIC VARIATION; GEOGRAPHY; GUINEA; HAPLOTYPES; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 84924987676     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2104.141355     Document Type: Article

References (15)

1. Buckle GC, Walker CL, Black RE. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health. 2012; 2:010401. http://dx.doi.org/10.7189/jogh.01.010401
2. Roumagnac P, Weill FX, Dolecek C, Baker S, Brisse S, Chinh NT, et al. Evolutionary history of Salmonella Typhi. Science. 2006; 314:1301–4. http://dx.doi.org/10.1126/science.1134933
3. Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, and Goodhead I, et al. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet. 2008; 40:987–93. http://dx.doi.org/10.1038/ng.195
4. Phan MD, Kidgell C, Nair S, Holt KE, Turner AK, Hinds J, et al. Variation in Salmonella enterica serovar Typhi IncHI1 plasmids during the global spread of resistant typhoid fever. Antimicrob Agents Chemother. 2009; 53:716–27. http://dx.doi.org/10.1128/AAC.00645-08
5. Holt KE, Phan MD, Baker S, Duy PT, Nga TV, Nair S, et al. Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid. PLoS Negl Trop Dis. 2011; 5:e1245. http://dx.doi.org/10.1371/journal.pntd.0001245
6. Kariuki S, Revathi G, Kiiru J, Mengo DM, Mwituria J, Muyodi J, et al. Typhoid in Kenya is associated with a dominant multidrugresistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol. 2010; 48:2171–6. http://dx.doi.org/10.1128/JCM.01983-09
7. Akinyemi KO, Coker AO. Trends of antibiotic resistance in Salmonella enterica serovar typhi isolated from hospitalized patients from 1997 to 2004 in Lagos, Nigeria. Indian J Med Microbiol. 2007; 25:436–7. http://dx.doi.org/10.4103/0255-0857.37369
8. Mills-Robertson F, Addy ME, Mensah P, Crupper SS. Molecular characterization of antibiotic resistance in clinical Salmonella typhi isolated in Ghana. FEMS Microbiol Lett. 2002; 215:249–53. http://dx.doi.org/10.1111/j.1574-6968.2002.tb11398.x
9. Gross U, Amuzu SK, de Ciman R, Kassimova I, Gross L, Rabsch W, et al. Bacteremia and antimicrobial drug resistance over time, Ghana. Emerg Infect Dis. 2011; 17:1879–82. http://dx.doi.org/10.3201/edi1710.110327
10. Dagnra AY, Akolly K, Gbadoe A, Aho K, and David M. Emergence of multidrug resistant Salmonella strains in Lome (Togo) [in French]. Med Mal Infect. 2007; 37:266–9. http://dx.doi.org/10.1016/j.medmal.2007.02.002
11. Lunguya O, Lejon V, Phoba MF, Bertrand S, Vanhoof R, Verhaegen J, et al.. Salmonella Typhi in the Democratic Republic of the Congo: fluoroquinolone decreased susceptibility on the rise. EPLoS Negl Trop Dis. 2012; 6:e1921. Doe: 10.1371/ journal.pntd.0001921. Pub 2012 Nov 5.
12. Cooke FJ, Day M, Wain J, Ward LR, Threlfall EJ. Cases of typhoid fever imported to England, Scotland and Wales (2000–2003). Trans R Soc Trop Med Hyg. 2007; 101:398–404. http://dx.doi.org/10.1016/j.trstmh.2006.07.005
13. Loury P, Tillaut H, Faisant M, Paillereau N, Marquis M, Mari C, et al. Cluster of typhoid fever cases in Ille-et-Vilaine (France), April 2009 [in French]. Bull Epidémiol Hebd. 2010; 44:446–8.
14. Le Hello S, Harrois D, Bouchrif B, Sontag L, Elhani D, Guibert V, et al. Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. Lancet Infect Dis. 2013; 13:672–9. http://dx.doi.org/10.1016/S1473-3099(13)70124-5
15. Fabre L, Le Hello S, Roux C, Issenhuth-Jeanjean S, Weill FX. CRISPR is an optimal target for the design of specific PCR assays for Salmonella enterica serotypes Typhi and Paratyphi A. PLoS Negl Trop Dis. 2014;8:e2671. http://dx.doi.org/10.1371/journal.pntd.0002671